It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor.
It is planned to prospectively collect, collate and report real-world clinical data of BSTS patients treated in our hospital in the next ten years to evaluate the changes in clinical characteristics, treatment patterns and survival information of these patients, in order to provide reference for clinical treatment and research of this type of tumor. This study is a single-center, prospective, real-world observational study that plans to enroll all eligible patients. Basic information, treatment methods, and prognostic information of these patients were collected.
Study Type
OBSERVATIONAL
Enrollment
6,000
NO Intervention
Department of Bone and Soft Tissue ,Henan Cancer Hospital
Zhengzhou, Henan, China
RECRUITINGOverall survival
Pathologically confirmed events leading to death
Time frame: Up to approximately 120months
6/5000 Progression-free survival
The time from the first use of the treatment to the observation of disease progression
Time frame: Up to approximately 48months
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.